Clinical trial
Relapse Prevention for Bipolar Type-II Disorder
NCT00044616 · University of Pennsylvania, Other · Completed
Key facts
| NCT number | NCT00044616 |
|---|---|
| Title | Relapse Prevention for Bipolar Type-II Disorder |
| Official title | Relapse Prevention of Bipolar Type-II Disorder |
| Lead sponsor | University of Pennsylvania, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Disorder, Depression |
| Intervention type | Drug |
| Interventions | Fluoxetine, Lithium |
| Enrollment | 180 |
| Start date | Feb 1, 2001 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Sep 5, 2002 |
| Last update posted | Oct 6, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: